Low-level laser in the treatment of carpal tunnel syndrome: clinical, electrophysiological, and ultrasonographical evaluation
Tascioglu F, Degirmenci NA, Ozkan S, Mehmetoglu O
Rheumatology international · 32 citas
Etiquetas de revisión
Financiación no declaradaDatos neutrales que nuestra revisión registró sobre cómo se hizo este estudio. Describen el método, nunca si nos gusta el resultado.
Cómo se estudió
- Diseño
- Ensayo controlado aleatorizado (indexado por PubMed)
- Estudiado en
- Personas
- Resultado principal
- Marcadores de salud y funcionamiento
Quién lo pagó
- Financiación
- Financiación no declarada
Publicación
- Publicado
- 2010-11-30 · Rheumatol Int · vol. 32 · número 2 · págs. 409–415
- Editorial
- Springer Science+Business Media
- Citado
- 57 citas · más que el 80% de estudios similares · 1.4× el promedio de su campo
- Referencias
- 35 trabajos
- Acceso
- De pago
- Áreas de investigación
- Laser Applications in Dentistry and Medicine · Peripheral Nerve Disorders · Pain Management and Treatment
- Palabras clave
- carpal tunnel syndrome, low-level laser therapy, diode laser, laser dose, median nerve, nerve conduction, grip strength, symptom severity, functional status, nerve cross-sectional area, placebo comparison
- MeSH
- median nerve, humans, carpal tunnel syndrome, ultrasonography, treatment outcome, prospective studies, double-blind method, dose-response relationship, radiation, adult, aged, middle aged, female, male, low-level light therapy
4 autores
- Funda Taşçıoğlu🇹🇷 · autor de correspondenciaEskişehir Osmangazi University
- Nevbahar Akçar🇹🇷Eskişehir Osmangazi University
- Serhat Özkan🇹🇷Eskişehir Osmangazi University
- Özlem Mehmetoglu🇹🇷Eskişehir Osmangazi University
Resumen
El texto original del estudio, en el idioma en que se publicó.
The objective of this study is to investigate the efficacy of low-level laser therapy (LLLT) in patients with carpal tunnel syndrome (CTS). Sixty patients with CTS were included in this placebo-controlled and double-blind study and randomly assigned to three treatment groups: active laser with a dosage of 1.2 J/per painful point, active laser with a dosage of 0.6 J/per painful point, and placebo groups. A total of 5 points across the median nerve trace were irradiated with Gal-Al-As diode laser. All groups were treated 5 times per week for 3 weeks. Clinical assessments included pain intensity, grip strength, symptom severity score (SSS), functional status score (FSS), nerve conduction studies, and cross-sectional area (CSA) of the median nerve as measured by ultrasonography. Compared to baseline, post-treatment VAS scores (group 1, P < 0.001; group 2, P < 0.001; group 3, P < 0.01), grip strength (P < 0.05), SSS scores (group 1, P < 0.001; group 2, P < 0.001; group 3, P < 0.01), and FSS scores (P < 0.05) improved significantly in all groups. Only sensorial nerve velocity measurements on the palmar region showed a significant improvement in both active laser groups (P < 0.01). There was no significant difference in any of the outcome measures among the groups. With the chosen laser type and dose regimen, the results suggested that LLLT was no more effective than placebo in CTS.
Resumen vía Europe PMC. Los derechos de autor siguen siendo de los autores o la editorial.
Confianza de la comunidad
Cargando…
¿Cuánto confías en los hallazgos de este estudio?
Comentarios
¿Algo está mal aquí?
Señala este estudio si su información, etiquetas o financiación parecen incorrectas. Un editor revisa cada señalamiento.
Información educativa sobre investigación publicada. No es consejo médico ni una recomendación para empezar o dejar nada.